Institutional investors purchased a net $3.3 million shares of PDLI during the quarter ended September 2016 and now own 79.24% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 2.6 Million shares of PDL BioPharma Inc
THE VANGUARD GROUP, INC. Bought 2.1 Million shares of PDL BioPharma Inc